{"status": "ok", "totalResults": 3, "articles": [{"source": {"id": null, "name": "Embedded.com"}, "author": "Florian Petit", "title": "How lidar is becoming smart and going beyond just automotive - Embedded", "description": "Lidar is vital for autonomous vehicles but no longer confined to self-driving cars; we explore the tech and how it is also becoming smarter.", "url": "https://www.embedded.com/how-lidar-is-becoming-smart-and-going-beyond-just-automotive/", "urlToImage": "https://www.embedded.com/wp-content/uploads/2023/10/Blickfeld-Pointcloud-Security-Zone.jpg", "publishedAt": "2023-10-27T11:47:33Z", "content": "The increasing interest in autonomous vehicles has spurred significant developments in lidar technology. These 3D lidar sensors are highly valued for their accurate environmental perception by measur\u2026 [+8415 chars]"}, {"source": {"id": null, "name": "Hindustan Times"}, "author": "HT Tech", "title": "Mangalyaan-2: How the second Mars mission is different from MOM-1 - HT Tech", "description": "ISRO is planning Mars orbiter mission 2. Know how Mangalyaan-2 will be different from the first mission.", "url": "https://tech.hindustantimes.com/photos/mangalyaan2-how-the-second-mars-mission-is-different-from-mom1-71698390533270.html", "urlToImage": "https://images.hindustantimes.com/tech/img/2023/10/27/1600x900/ge7ecf_1698390597609_1698390597744.png", "publishedAt": "2023-10-27T07:14:14Z", "content": "Top SectionsExplore Tech Copyright \u00a9 HT Media Limited All rights reserved."}, {"source": {"id": "the-hill", "name": "The Hill"}, "author": "Joseph Choi", "title": "Combined COVID-flu vaccine from Pfizer, BioNTech moving to late-stage testing - The Hill", "description": "Pfizer and BioNTech announced Thursday it would soon begin a Phase 3 trial for its combined flu and COVID-19 mRNA vaccine following \u201cpositive\u201d results from its Phase 1/2 study. Phase 1 and 2 trials are meant to evaluate whether a new drug or treatment is both\u2026", "url": "https://thehill.com/policy/healthcare/4277248-pfizer-biontech-flu-covid-vaccine-phase-3-trial/", "urlToImage": "https://thehill.com/wp-content/uploads/sites/2/2023/08/64c937002d7386.96347602-e1698349991351.jpeg?w=1280", "publishedAt": "2023-10-26T19:53:00Z", "content": "Skip to content\r\nPfizer and BioNTech announced Thursday it would soon begin a Phase 3 trial for its combined flu and COVID-19 mRNA vaccine following \u201cpositive\u201d results from its Phase 1/2 study.\r\nPhas\u2026 [+1715 chars]"}]}